Silvestro Stephen L (CIK 1773461) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-24). Recent activity: Buy OPRX (79,200 shares), Sell OPRX (1,737 shares), Sell OPRX (5,219 shares), Sell OPRX (3,361 shares), Sell OPRX (3,361 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Buy | 79,200 | $0 |
| 2026-08-24 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Sell | 1,737 | $13,392 |
| 2026-05-18 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Sell | 5,219 | $27,191 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Sell | 3,361 | $42,819 |
| 2025-12-23 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Sell | 3,361 | $42,819 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Buy | 6,546 | $0 |
| 2025-12-22 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Sell | 1,594 | $21,535 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Buy | 6,649 | $0 |
| 2025-10-07 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Sell | 1,620 | $30,375 |
| 2025-08-25 | OptimizeRx Corp (OPRX) | Chief Executive Officer | Buy | 15,625 | $0 |
| 2025-05-19 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | Buy | 46,948 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-24